Difficulty: Medium
Average Score: 95%
Practice
Granulocytic sarcoma masses are commonly seen in which type of the following malignancies?
Correct answer
D
Rationale
The correct answer is D) AML (acute myeloid leukemia). Granulocytic sarcoma, also known as chloroma, is a rare extramedullary manifestation of AML where myeloid blasts form tumors outside of the bone marrow. This condition can present as a mass in various locations, including soft tissues.
Option A) neuroblastoma is a tumor of the sympathetic nervous system and is not associated with granulocytic sarcoma. Option B) rhabdomyosarcoma is a soft tissue tumor arising from skeletal muscle, not from myeloid blasts. Option C) soft tissue sarcoma encompasses various tumors arising from soft tissues but is not specifically linked to granulocytic sarcoma.
In a pediatric primary care context, understanding the association between granulocytic sarcoma and AML is crucial for early detection and appropriate management. It highlights the need for comprehensive assessment and consideration of hematologic malignancies in the differential diagnosis of soft tissue masses in children. This knowledge can guide healthcare providers in timely referrals and treatment interventions for better patient outcomes.
Option A) neuroblastoma is a tumor of the sympathetic nervous system and is not associated with granulocytic sarcoma. Option B) rhabdomyosarcoma is a soft tissue tumor arising from skeletal muscle, not from myeloid blasts. Option C) soft tissue sarcoma encompasses various tumors arising from soft tissues but is not specifically linked to granulocytic sarcoma.
In a pediatric primary care context, understanding the association between granulocytic sarcoma and AML is crucial for early detection and appropriate management. It highlights the need for comprehensive assessment and consideration of hematologic malignancies in the differential diagnosis of soft tissue masses in children. This knowledge can guide healthcare providers in timely referrals and treatment interventions for better patient outcomes.